Work package 5 leader
Daniela Marino is the CEO and co-founder of CUTISS, a Swiss Life Science company, spin-off of the University of Zurich. Daniela holds a master in Biotechnology and a PhD in Sciences from ETHZ. During her PhD and her PostDoc, her research focussed primarily on vascular biology and skin engineering. In 2017, She co-founded CUTISS, where denovoSkin™ is developed towards commercialization. denovoSkin™ is a personalized, dermo-epidermal skin graft bioengineered to treat patients suffering from severe skin injuries and defects.